Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
ALS ( (AU:ALQ) ) has issued an announcement.
ALS reported a strong financial performance for the first half of the fiscal year 2026, with a 14.7% increase in underlying EBIT and a 13.3% rise in revenue, driven by robust growth in the commodities sector. The company maintained resilient margins despite price discounting in previous quarters and achieved significant organic growth in its minerals and life sciences segments. ALS’s strategic capital deployment and balance sheet strength position it well for continued growth, with a declared interim dividend reflecting confidence in its financial health.
The most recent analyst rating on (AU:ALQ) stock is a Buy with a A$23.50 price target. To see the full list of analyst forecasts on ALS stock, see the AU:ALQ Stock Forecast page.
More about ALS
ALS is a diversified global testing company operating primarily in the commodities and life sciences sectors. The company provides testing services for minerals, food, and environmental samples, with a strong market focus on APAC, EMEA, and the Americas.
YTD Price Performance: 41.00%
Average Trading Volume: 1,384,293
Technical Sentiment Signal: Buy
Current Market Cap: A$10.66B
For a thorough assessment of ALQ stock, go to TipRanks’ Stock Analysis page.